Literature DB >> 1280830

A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.

G Hartmann1, L Naldini, K M Weidner, M Sachs, E Vigna, P M Comoglio, W Birchmeier.   

Abstract

We recently found that scatter factor (SF), a cell motility factor with a multimodular structure, is identical to hepatocyte growth factor (HGF), a potent mitogen of various cell types. SF/HGF is the ligand of the c-Met receptor tyrosine kinase. Here we used transient expression of naturally occurring and in vitro mutagenized cDNAs of SF/HGF to delineate the protein domains necessary for biological activity and binding to the c-Met receptor. (i) A single-chain SF/HGF resulting from the destruction of the protease cleavage site between heavy and light chain (Arg-494--> Gln) was largely inactive, indicating that proteolytic cleavage is essential for acquisition of the biologically active conformation. (ii) A SF/HGF splice variant encoding a protein with a 5-amino acid deletion in the first kringle domain was as highly active as the wild-type molecule. (iii) The separately expressed light chain (with serine protease homology) was inactive in all assays tested. (iv) The separate heavy chain as well as a naturally occurring splice variant consisting of the N terminus and the first two kringle domains bound the c-Met receptor, stimulated tyrosine auto-phosphorylation, and induced scattering of epithelial cells but not mitogenesis. These data indicate that a functional domain in the N terminus/first two kringle regions of SF/HGF is sufficient for binding to the Met receptor and that this leads to the activation of the downstream signal cascade involved in the motility response. However, the complete SF/HGF protein seems to be required for mitogenic activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280830      PMCID: PMC50595          DOI: 10.1073/pnas.89.23.11574

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Mammalian subtilisins: the long-sought dibasic processing endoproteases.

Authors:  P J Barr
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

2.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

Authors:  J S Rubin; A M Chan; D P Bottaro; W H Burgess; W G Taylor; A C Cech; D W Hirschfield; J Wong; T Miki; P W Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 3.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

4.  Expression of the Met/HGF receptor in normal and neoplastic human tissues.

Authors:  M F Di Renzo; R P Narsimhan; M Olivero; S Bretti; S Giordano; E Medico; P Gaglia; P Zara; P M Comoglio
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

5.  A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.

Authors:  A Isacchi; M Statuto; R Chiesa; L Bergonzoni; M Rusnati; P Sarmientos; G Ragnotti; M Presta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors.

Authors:  M Prat; R P Narsimhan; T Crepaldi; M R Nicotra; P G Natali; P M Comoglio
Journal:  Int J Cancer       Date:  1991-09-30       Impact factor: 7.396

7.  Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor.

Authors:  Y Yoshiyama; N Arakaki; D Naka; K Takahashi; S Hirono; J Kondo; H Nakayama; E Gohda; N Kitamura; H Tsubouchi
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

8.  Evidence for the identity of human scatter factor and human hepatocyte growth factor.

Authors:  K M Weidner; N Arakaki; G Hartmann; J Vandekerckhove; S Weingart; H Rieder; C Fonatsch; H Tsubouchi; T Hishida; Y Daikuhara
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.

Authors:  R Montesano; K Matsumoto; T Nakamura; L Orci
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

10.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.

Authors:  U H Frixen; J Behrens; M Sachs; G Eberle; B Voss; A Warda; D Löchner; W Birchmeier
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

View more
  61 in total

1.  Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis.

Authors:  Hiroyuki Ohnishi; Kiyomasa Oka; Shinya Mizuno; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

Review 2.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

3.  Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.

Authors:  Wilfred W Raymond; Anthony C Cruz; George H Caughey
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

4.  Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism.

Authors:  P Chen; H Xie; A Wells
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

5.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.

Authors:  S Lin; D Rusciano; P Lorenzoni; G Hartmann; W Birchmeier; S Giordano; P Comoglio; M M Burger
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

7.  Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

Authors:  S J Stahl; P T Wingfield; J D Kaufman; L K Pannell; V Cioce; H Sakata; W G Taylor; J S Rubin; D P Bottaro
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

8.  Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.

Authors:  T Otsuka; J Jakubczak; W Vieira; D P Bottaro; D Breckenridge; W J Larochelle; G Merlino
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.

Authors:  B Cao; Y Su; M Oskarsson; P Zhao; E J Kort; R J Fisher; L M Wang; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 10.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.